Welcome to LookChem.com Sign In|Join Free

CAS

  • or

60410-16-4

Post Buying Request

60410-16-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

60410-16-4 Usage

Description

(1R,3S)-4-Cyclopentene-1,3-diol 1-acetate is a chiral organic compound characterized by its unique cyclopentane ring structure and functional groups. It possesses a 1,3-diol motif with one acetate group attached, which makes it a versatile intermediate in organic synthesis. (1R,3S)-4-CYCLOPENTENE-1,3-DIOL 1-ACETATE is known for its potential applications in the pharmaceutical and chemical industries due to its ability to form various derivatives and participate in numerous chemical reactions.

Uses

Used in Pharmaceutical Industry:
(1R,3S)-4-Cyclopentene-1,3-diol 1-acetate is used as a building block for the synthesis of biologically significant carbocyclic nucleosides and prostaglandins. Its unique structure allows it to be a key component in the development of new drugs with potential therapeutic applications.
Used in Chemical Synthesis:
(1R,3S)-4-Cyclopentene-1,3-diol 1-acetate is used as a starting material in the synthesis of azasugar analogs. Azasugars are a class of compounds that have the potential to inhibit enzymes involved in carbohydrate metabolism, making them useful in the development of treatments for diabetes and other metabolic disorders.

Check Digit Verification of cas no

The CAS Registry Mumber 60410-16-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,0,4,1 and 0 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 60410-16:
(7*6)+(6*0)+(5*4)+(4*1)+(3*0)+(2*1)+(1*6)=74
74 % 10 = 4
So 60410-16-4 is a valid CAS Registry Number.
InChI:InChI=1/C7H10O3/c1-5(8)10-7-3-2-6(9)4-7/h2-3,6-7,9H,4H2,1H3/t6-,7+/m1/s1

60410-16-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (446041)  (1S,4R)-cis-4-Acetoxy-2-cyclopenten-1-ol  ≥99%

  • 60410-16-4

  • 446041-1G

  • 2,908.62CNY

  • Detail

60410-16-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name (1R,3S)-(+)-4-Cyclopentene-1,3-diol 1-acetate

1.2 Other means of identification

Product number -
Other names [(1R,4S)-4-hydroxycyclopent-2-en-1-yl] acetate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:60410-16-4 SDS

60410-16-4Synthetic route

cis-1,4-diacetoxy-2-cyclopentene
54664-61-8

cis-1,4-diacetoxy-2-cyclopentene

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

Conditions
ConditionsYield
With Novosyme sp 435 lipase In various solvent(s) at 20℃; for 18h; pH=8;96%
With Novozym 43596%
With lipase from candida antartica In aq. phosphate buffer at 20℃; for 24h; pH=8; Enzymatic reaction; enantioselective reaction;96%
cis-1,4-diacetoxy-2-cyclopentene
54664-61-8

cis-1,4-diacetoxy-2-cyclopentene

A

(1S,4R)-4-hydroxy-2-cyclopentenyl acetate
60176-77-4

(1S,4R)-4-hydroxy-2-cyclopentenyl acetate

B

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

Conditions
ConditionsYield
With methanol; lipase B from Candida antarctica In tert-butyl methyl ether at 5℃; for 16h; Enzymatic reaction; enantioselective reaction;A n/a
B 95%
With sodium hydroxide; Esterase(porcine liver)PLE In water at 32℃; for 8h; Product distribution; further enzymes; pH=7, phosphate buffer;
With N-(2-acetamido)-2-aminoethanesulfonic acid; ethanolamine; 2-amino-2-hydroxymethyl-1,3-propanediol at 37℃; for 8h; Product distribution; antibody of IgG class: 37E8, pH 8.0; Km, Kcat, Ki; var. enzymes and time;
(-)-acetic acid cis-4-(tetrahydro-pyran-2-yloxy)-cyclopent-2-enyl ester
61305-31-5

(-)-acetic acid cis-4-(tetrahydro-pyran-2-yloxy)-cyclopent-2-enyl ester

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

Conditions
ConditionsYield
With toluene-4-sulfonic acid In ethanol; ethyl acetate91%
cis-4-cyclopentene-1,3-diol
29783-26-4

cis-4-cyclopentene-1,3-diol

acetic anhydride
108-24-7

acetic anhydride

A

cis-1,4-diacetoxy-2-cyclopentene
54664-61-8

cis-1,4-diacetoxy-2-cyclopentene

B

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

Conditions
ConditionsYield
Stage #1: cis-4-cyclopentene-1,3-diol With (4-(pyridin-4-yl)-4,5-dihydro-3H-dinaphtho[2,1-c:1′,2′-e]azepine-2,6-diyl)bis(bis(4-((tertbutyldimethylsilyl)oxy)phenyl)methanol); N-ethyl-N,N-diisopropylamine In tert-butyl methyl ether at -40℃; for 0.25h;
Stage #2: acetic anhydride In tert-butyl methyl ether at -40℃; for 6h; Temperature; Time; enantioselective reaction;
A n/a
B 89%
cis-3,5-diacetoxycyclopentene

cis-3,5-diacetoxycyclopentene

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

Conditions
ConditionsYield
With Candida antartica lipase B In aq. phosphate buffer for 3.5h; pH=7; Enzymatic reaction;85%
(1R,4S)-4-[(tert-butyldimethylsilyl)oxy]-2-cyclopentene-1-yl acetate
115074-49-2

(1R,4S)-4-[(tert-butyldimethylsilyl)oxy]-2-cyclopentene-1-yl acetate

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

Conditions
ConditionsYield
With tetrabutyl ammonium fluoride82%
vinyl acetate
108-05-4

vinyl acetate

cis-4-cyclopentene-1,3-diol

cis-4-cyclopentene-1,3-diol

A

cis-1,4-diacetoxy-2-cyclopentene
54664-61-8

cis-1,4-diacetoxy-2-cyclopentene

B

(1S,4R)-4-hydroxy-2-cyclopentenyl acetate
60176-77-4

(1S,4R)-4-hydroxy-2-cyclopentenyl acetate

C

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

Conditions
ConditionsYield
lipase EC 3.1.1.3 L10 In water; acetone at 5 - 25℃; for 6.5h; Product distribution / selectivity;A n/a
B 76.4%
C n/a
lipase EC 3.1.1.3 QLC In water; acetone at 5 - 25℃; for 6.5h; Product distribution / selectivity;A n/a
B 76.4%
C n/a
lipase EC 3.1.1.3 QL In water; acetone at 5 - 25℃; for 6.5h; Product distribution / selectivity;A n/a
B 75.5%
C n/a
lipase EC 3.1.1.3 QLG In water; acetone at 5 - 25℃; for 6.5h; Product distribution / selectivity;A n/a
B 61.9%
C n/a
pancreatin lipase In water; acetone at 5 - 25℃; for 6.5h; Product distribution / selectivity;A n/a
B 16.5%
C n/a
meso-cis-1,4-diacetoxy-2-cyclopentene
60389-71-1, 60410-14-2, 61826-75-3

meso-cis-1,4-diacetoxy-2-cyclopentene

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

Conditions
ConditionsYield
With novozyme 435 In aq. phosphate buffer at 4℃; for 18h; pH=6; pH-value; Temperature; Time; Enzymatic reaction;76%
With porcine liver esterase; phosphate buffer at 37℃; for 48h; pH=7.0; Hydrolysis;34%
With sodium hydroxide; Lipase PS Amano In water pH=7; Product distribution / selectivity; phosphate buffer; Enzymatic reaction;n/a
With sodium hydroxide; Novo SP435 In water pH=7; Product distribution / selectivity; phosphate buffer; Enzymatic reaction;
vinyl acetate
108-05-4

vinyl acetate

cis-4-cyclopentene-1,3-diol
29783-26-4

cis-4-cyclopentene-1,3-diol

A

cis-1,4-diacetoxy-2-cyclopentene
54664-61-8

cis-1,4-diacetoxy-2-cyclopentene

B

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran for 2.5h; Ambient temperature; Pancreatin as lipase;A 32%
B 65%
With triethylamine In tetrahydrofuran for 2h; Ambient temperature; Candida sp. 382 as lipase;A 40%
B 53%
vinyl acetate
108-05-4

vinyl acetate

cis-4-cyclopentene-1,3-diol
29783-26-4

cis-4-cyclopentene-1,3-diol

A

cis-1,4-diacetoxy-2-cyclopentene
54664-61-8

cis-1,4-diacetoxy-2-cyclopentene

B

(1S,4R)-4-hydroxy-2-cyclopentenyl acetate
60176-77-4

(1S,4R)-4-hydroxy-2-cyclopentenyl acetate

C

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran at 20℃; for 23h; Enzymatic reaction; enantioselective reaction;A 25%
B 61%
C n/a
2,2,2-trichloroethyl acetate
625-24-1

2,2,2-trichloroethyl acetate

cis-4-cyclopentene-1,3-diol
29783-26-4

cis-4-cyclopentene-1,3-diol

A

(1S,4R)-4-hydroxy-2-cyclopentenyl acetate
60176-77-4

(1S,4R)-4-hydroxy-2-cyclopentenyl acetate

B

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

Conditions
ConditionsYield
pancreatin/base;

A

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

B

(1R,4R)-(+)-4-Hydroxy-2-cyclopentenyl acetate
60410-17-5

(1R,4R)-(+)-4-Hydroxy-2-cyclopentenyl acetate

Conditions
ConditionsYield
With potassium hydroxide; pig pancreatic lipase at 37℃; for 8h; 0.1 M phosphate buffer (pH 7); Yield given. Yields of byproduct given;
Acetic acid (1R,4S)-4-(tetrahydro-pyran-2-yloxy)-cyclopent-2-enyl ester
142130-74-3

Acetic acid (1R,4S)-4-(tetrahydro-pyran-2-yloxy)-cyclopent-2-enyl ester

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

Conditions
ConditionsYield
With toluene-4-sulfonic acid In ethanol for 2h; Ambient temperature; Yield given;
(1S,4R)-(-)-4-(2'R*-tetrahydropyranyloxy)-2-cyclopentenyl acetate
95722-35-3

(1S,4R)-(-)-4-(2'R*-tetrahydropyranyloxy)-2-cyclopentenyl acetate

A

(1S,4R)-4-hydroxy-2-cyclopentenyl acetate
60176-77-4

(1S,4R)-4-hydroxy-2-cyclopentenyl acetate

B

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

Conditions
ConditionsYield
With toluene-4-sulfonic acid In ethanol for 2h; Ambient temperature; Yield given. Yields of byproduct given. Title compound not separated from byproducts;
C9H9(2)H3O4

C9H9(2)H3O4

A

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

B

C7H7(2)H3O3

C7H7(2)H3O3

Conditions
ConditionsYield
With porcine liver esterase Hydrolysis;
acetic anhydride
108-24-7

acetic anhydride

/PXFCB296--150/

/PXFCB296--150/

B

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

Conditions
ConditionsYield
Yield given. Multistep reaction. Yields of byproduct given. Title compound not separated from byproducts;
(1R,4S)-4-(tert-butyldimethylsilyloxy)cyclopent-2-enol
120520-91-4

(1R,4S)-4-(tert-butyldimethylsilyloxy)cyclopent-2-enol

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 99 percent / Et3N; DMAP
2: 82 percent / TBAF
View Scheme
(2-furyl)methyl alcohol
98-00-0

(2-furyl)methyl alcohol

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 53 percent / KH2PO4, H3PO4 / H2O / 40 h / 99 °C / pH 4.1
2: 76 percent / PPTs / tetrahydrofuran / 18 h / Ambient temperature
3: LiAlH4, LiI / various solvent(s); toluene / 0.5 h / -20 - -13 °C
4: 50 percent / Et3N, pancreatin, vinyl acetate / various solvent(s) / 7 h / Ambient temperature
5: DMAP / pyridine / 16 h / Ambient temperature
6: p-TsOH / ethanol / 2 h / Ambient temperature
View Scheme
Multi-step reaction with 5 steps
1: 53 percent / KH2PO4, H3PO4 / H2O / 40 h / 99 °C / pH 4.1
2: 76 percent / PPTs / tetrahydrofuran / 18 h / Ambient temperature
3: LiAlH4, LiI / various solvent(s); toluene / 0.5 h / -20 - -13 °C
4: 45 percent / Et3N, pancreatin, vinyl acetate / various solvent(s) / 7 h / Ambient temperature
5: p-TsOH / ethanol / 2 h / Ambient temperature
View Scheme
Multi-step reaction with 4 steps
1: potassium dihydrogenphosphate; phosphoric acid / water / 22 h / 25 - 99 °C / pH 4.1
2: sodium tetrahydroborate; cerium(III) chloride heptahydrate / methanol / 2 h / -70 - -60 °C
3: dmap; triethylamine / N,N-dimethyl-formamide / 16 h / 10 - 30 °C / Inert atmosphere
4: disodium hydrogenphosphate / water / 14 h / 25 - 30 °C / pH 7 / Enzymatic reaction
View Scheme
(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 76 percent / PPTs / tetrahydrofuran / 18 h / Ambient temperature
2: LiAlH4, LiI / various solvent(s); toluene / 0.5 h / -20 - -13 °C
3: 50 percent / Et3N, pancreatin, vinyl acetate / various solvent(s) / 7 h / Ambient temperature
4: DMAP / pyridine / 16 h / Ambient temperature
5: p-TsOH / ethanol / 2 h / Ambient temperature
View Scheme
Multi-step reaction with 4 steps
1: 76 percent / PPTs / tetrahydrofuran / 18 h / Ambient temperature
2: LiAlH4, LiI / various solvent(s); toluene / 0.5 h / -20 - -13 °C
3: 45 percent / Et3N, pancreatin, vinyl acetate / various solvent(s) / 7 h / Ambient temperature
4: p-TsOH / ethanol / 2 h / Ambient temperature
View Scheme
Multi-step reaction with 3 steps
1: sodium tetrahydroborate; cerium(III) chloride heptahydrate / methanol / 2 h / -70 - -60 °C
2: dmap; triethylamine / N,N-dimethyl-formamide / 16 h / 10 - 30 °C / Inert atmosphere
3: disodium hydrogenphosphate / water / 14 h / 25 - 30 °C / pH 7 / Enzymatic reaction
View Scheme
(1R,4S)-(-)-4-(2'R*-tetrahydropyranyloxy)-2-cyclopentenol
63640-56-2

(1R,4S)-(-)-4-(2'R*-tetrahydropyranyloxy)-2-cyclopentenol

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: DMAP / pyridine / 16 h / Ambient temperature
2: p-TsOH / ethanol / 2 h / Ambient temperature
View Scheme
4-(tetrahydro-pyran-2-yloxy)-cyclopent-2-enone
61305-37-1, 62356-78-9, 70615-05-3

4-(tetrahydro-pyran-2-yloxy)-cyclopent-2-enone

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: LiAlH4, LiI / various solvent(s); toluene / 0.5 h / -20 - -13 °C
2: 50 percent / Et3N, pancreatin, vinyl acetate / various solvent(s) / 7 h / Ambient temperature
3: DMAP / pyridine / 16 h / Ambient temperature
4: p-TsOH / ethanol / 2 h / Ambient temperature
View Scheme
Multi-step reaction with 3 steps
1: LiAlH4, LiI / various solvent(s); toluene / 0.5 h / -20 - -13 °C
2: 45 percent / Et3N, pancreatin, vinyl acetate / various solvent(s) / 7 h / Ambient temperature
3: p-TsOH / ethanol / 2 h / Ambient temperature
View Scheme
(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 50 percent / Et3N, pancreatin, vinyl acetate / various solvent(s) / 7 h / Ambient temperature
2: DMAP / pyridine / 16 h / Ambient temperature
3: p-TsOH / ethanol / 2 h / Ambient temperature
View Scheme
Multi-step reaction with 2 steps
1: 45 percent / Et3N, pancreatin, vinyl acetate / various solvent(s) / 7 h / Ambient temperature
2: p-TsOH / ethanol / 2 h / Ambient temperature
View Scheme
cis-4-cyclopentene-1,3-diol
29783-26-4

cis-4-cyclopentene-1,3-diol

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: dmap; triethylamine / N,N-dimethyl-formamide / 16 h / 10 - 30 °C / Inert atmosphere
2: disodium hydrogenphosphate / water / 14 h / 25 - 30 °C / pH 7 / Enzymatic reaction
View Scheme
Multi-step reaction with 2 steps
1: triethylamine / tetrahydrofuran / 23 h / 20 °C / Enzymatic reaction
2: lipase from candida antartica / aq. phosphate buffer / 24 h / 20 °C / pH 8 / Enzymatic reaction
View Scheme
Multi-step reaction with 2 steps
1: triethylamine / tetrahydrofuran / 24 h / 20 °C / Enzymatic reaction
2: lipase from candida antartica / aq. phosphate buffer / 24 h / 20 °C / pH 8 / Enzymatic reaction
View Scheme
Multi-step reaction with 2 steps
1: triethylamine; lipase from candida antartica / tetrahydrofuran / 0.5 h / 20 °C / Enzymatic reaction
2: lipase from candida antartica / aq. phosphate buffer / 24 h / 20 °C / pH 8 / Enzymatic reaction
View Scheme
6-oxabicyclo[3.1.0]hex-2-ene
7129-41-1

6-oxabicyclo[3.1.0]hex-2-ene

acetic acid
64-19-7

acetic acid

A

(1S,4R)-4-hydroxy-2-cyclopentenyl acetate
60176-77-4

(1S,4R)-4-hydroxy-2-cyclopentenyl acetate

B

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

Conditions
ConditionsYield
With tetrakis(triphenylphosphine) palladium(0); Triethylene glycol dimethyl ether In tetrahydrofuran at 0℃; for 1h; Reagent/catalyst; Solvent; Schlenk technique; Inert atmosphere; Overall yield = 85 %Chromat.;A n/a
B n/a
cyclopenta-1,3-diene
542-92-7

cyclopenta-1,3-diene

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: (-)-chloro((1R,2R)-4,4',6,6'-tetra-tert-butyl-2,2'-[cyclohexane-1,2-diylbis(nitrilomethylidyne)]diphenolato)manganese(III); 4-Phenylpyridine 1-oxide; sodium hypochlorite / dichloromethane / 5 h / 4 °C
2: Triethylene glycol dimethyl ether; tetrakis(triphenylphosphine) palladium(0) / tetrahydrofuran / 1 h / 0 °C / Schlenk technique; Inert atmosphere
View Scheme
Multi-step reaction with 3 steps
1: oxygen; thiourea; Rose Bengal lactone / methanol / 19 °C / 6000.6 Torr / Irradiation
2: dmap; pyridine / 2 h / 0 - 7 °C / Inert atmosphere
3: novozyme 435 / aq. phosphate buffer / 18 h / 4 °C / pH 6 / Enzymatic reaction
View Scheme
cis-1,4-diacetoxy-2-cyclopentene
54664-61-8

cis-1,4-diacetoxy-2-cyclopentene

A

cis-4-cyclopentene-1,3-diol
29783-26-4

cis-4-cyclopentene-1,3-diol

B

(1S,4R)-4-hydroxy-2-cyclopentenyl acetate
60176-77-4

(1S,4R)-4-hydroxy-2-cyclopentenyl acetate

C

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

Conditions
ConditionsYield
With pseudomonas fluorescens lipase In hexane; water at 25℃; Reagent/catalyst; Enzymatic reaction; enantioselective reaction;
With lipase B from Candida antarctica In aq. phosphate buffer at 20℃; pH=7.5; Solvent; Enzymatic reaction;A n/a
B n/a
C n/a
cis-4-cyclopentene-1,3-diol diacetate

cis-4-cyclopentene-1,3-diol diacetate

A

(1S,4R)-4-hydroxy-2-cyclopentenyl acetate
60176-77-4

(1S,4R)-4-hydroxy-2-cyclopentenyl acetate

B

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

Conditions
ConditionsYield
With recombinant pig liver esterase In aq. phosphate buffer at 50℃; for 2h; pH=7.5; pH-value; Temperature; Solvent; Enzymatic reaction; enantioselective reaction;A n/a
B n/a
cis-3-acetoxy-5-hydroxycyclopent-1-ene
61740-26-9

cis-3-acetoxy-5-hydroxycyclopent-1-ene

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 1H-imidazole / dichloromethane / 0.17 h / 0 - 23 °C
2: Novozym 435 lipase / dichloromethane; aq. phosphate buffer / 23 - 24 °C / pH 8.0
View Scheme
6-oxabicyclo[3.1.0]hex-2-ene
7129-41-1

6-oxabicyclo[3.1.0]hex-2-ene

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: tetrakis(triphenylphosphine) palladium(0) / tetrahydrofuran / 0.33 h / 0 °C
2: 1H-imidazole / dichloromethane / 0.17 h / 0 - 23 °C
3: Novozym 435 lipase / dichloromethane; aq. phosphate buffer / 23 - 24 °C / pH 8.0
View Scheme
3,4-dihydro-2H-pyran
110-87-2

3,4-dihydro-2H-pyran

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

Acetic acid (1R,4S)-4-(tetrahydro-pyran-2-yloxy)-cyclopent-2-enyl ester
142130-74-3

Acetic acid (1R,4S)-4-(tetrahydro-pyran-2-yloxy)-cyclopent-2-enyl ester

Conditions
ConditionsYield
With toluene-4-sulfonic acid for 0.166667h; Ambient temperature;100%
With pyridinium p-toluenesulfonate In dichloromethane96%
With TSA In dichloromethane at 0℃; for 0.166667h;91%
(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

diethyl chlorophosphate
814-49-3

diethyl chlorophosphate

(1S,4R)-4-acetoxy-2-cyclopenten-1-yl diethyl phosphate
594857-54-2

(1S,4R)-4-acetoxy-2-cyclopenten-1-yl diethyl phosphate

Conditions
ConditionsYield
With pyridine In dichloromethane at 0 - 25℃; for 4.5h;100%
(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

(1R,4S)-4-[(tert-butyldimethylsilyl)oxy]-2-cyclopentene-1-yl acetate
115074-49-2

(1R,4S)-4-[(tert-butyldimethylsilyl)oxy]-2-cyclopentene-1-yl acetate

Conditions
ConditionsYield
With 1H-imidazole In tetrahydrofuran at 20℃;100%
With 1H-imidazole In tetrahydrofuran at 20℃; for 24h;100%
With 1H-imidazole In tetrahydrofuran at 20℃; for 24h;100%
(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

pivaloyl chloride
3282-30-2

pivaloyl chloride

(3R,5S)-(+)-3-acetoxy-5-(trimethylacetyloxy)cyclopent-1-ene
178034-11-2

(3R,5S)-(+)-3-acetoxy-5-(trimethylacetyloxy)cyclopent-1-ene

Conditions
ConditionsYield
With dmap; triethylamine In dichloromethane at 0℃; for 2h;100%
With dmap; triethylamine In dichloromethane at 0℃;99%
With dmap; triethylamine In dichloromethane at 0℃; for 0.75h;98%
(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

methanesulfonyl chloride
124-63-0

methanesulfonyl chloride

Acetic acid (1R,4R)-4-methanesulfonyloxy-cyclopent-2-enyl ester
177566-46-0

Acetic acid (1R,4R)-4-methanesulfonyloxy-cyclopent-2-enyl ester

Conditions
ConditionsYield
With triethylamine In dichloromethane Ambient temperature;100%
(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

1H-benzotriazole-1-carboxylic acid methyl ester 3-oxide
76266-27-8

1H-benzotriazole-1-carboxylic acid methyl ester 3-oxide

Acetic acid (1R,4S)-4-methoxycarbonyloxy-cyclopent-2-enyl ester

Acetic acid (1R,4S)-4-methoxycarbonyloxy-cyclopent-2-enyl ester

Conditions
ConditionsYield
With dmap; triethylamine In pyridine at 25℃;99%
N-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)-N-[2-{[(2S,3R,6S)-2-methoxy-6-{(2-nitrophenylsulfonamido)methyl}-3,6-dihydro-2H-pyran-3-yloxy]methyl}allyl]-4-methylbenzenesulfonamide
1120367-44-3

N-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)-N-[2-{[(2S,3R,6S)-2-methoxy-6-{(2-nitrophenylsulfonamido)methyl}-3,6-dihydro-2H-pyran-3-yloxy]methyl}allyl]-4-methylbenzenesulfonamide

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

C41H40F17N3O11S2
1252933-09-7

C41H40F17N3O11S2

Conditions
ConditionsYield
With triphenylphosphine; diethylazodicarboxylate In tetrahydrofuran at 0 - 20℃; Fukuyama-Mitsunobu reaction;98%
N-allyl-p-nitrobenzenesulfonamide
100704-44-7

N-allyl-p-nitrobenzenesulfonamide

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

C16H18N2O6S
1449016-83-4

C16H18N2O6S

Conditions
ConditionsYield
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 0 - 20℃; for 18h; Fukuyama Coupling;98%
(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

methyl chloroformate
79-22-1

methyl chloroformate

methyl (1S,4R)-4-acetoxy-2-cyclopentenylcarbonate
138318-67-9

methyl (1S,4R)-4-acetoxy-2-cyclopentenylcarbonate

Conditions
ConditionsYield
With pyridine In dichloromethane at 23℃;97%
With pyridine In dichloromethane at 0℃; for 2h;97%
With pyridine In dichloromethane at 0℃; for 1h;
Allylchlorodimethylsilane
4028-23-3

Allylchlorodimethylsilane

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

(1R,4S)-acetic acid 4-(allyldimethylsilanyloxy)cyclopent-2-enyl ester

(1R,4S)-acetic acid 4-(allyldimethylsilanyloxy)cyclopent-2-enyl ester

Conditions
ConditionsYield
With triethylamine In dichloromethane at 25℃; for 3h; Substitution;97%
<2-(13)C>acetyl chloride
14770-40-2

<2-(13)C>acetyl chloride

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

(1S,4R)-cis-1-(2-13C-acetoxy)-4-acetoxycyclopent-2-ene

(1S,4R)-cis-1-(2-13C-acetoxy)-4-acetoxycyclopent-2-ene

Conditions
ConditionsYield
With pyridine In dichloromethane at 0 - 20℃;97%
diiodomethane
75-11-6

diiodomethane

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

(1S,2R,4S,5R)-(+)-4-hydroxybicyclo<3.1.0>hex-2-yl acetate
137820-15-6

(1S,2R,4S,5R)-(+)-4-hydroxybicyclo<3.1.0>hex-2-yl acetate

Conditions
ConditionsYield
Stage #1: (1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate With Et2Zn In dichloromethane at 0℃; for 0.25h; Simmons-Smith cyclopropanation;
Stage #2: diiodomethane With Et2Zn In hexane; dichloromethane at 0 - 20℃;
97%
Stage #1: (1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate With diethylzinc In hexane; dichloromethane at 0℃;
Stage #2: diiodomethane With diethylzinc In hexane; dichloromethane at 0 - 20℃;
N-[(2R)-1-{[(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)bis(propan-2-yl)silyl]oxy}pent-4-en-2-yl]-2-nitrobenzene-1-sulfonamide

N-[(2R)-1-{[(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)bis(propan-2-yl)silyl]oxy}pent-4-en-2-yl]-2-nitrobenzene-1-sulfonamide

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

(1R,4R)-4-(N-((R)-1-((3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)diisopropylsilyloxy)-pent-4-en-2-yl)-2-nitrophenylsulfonamido)cyclopent-2-enyl acetate

(1R,4R)-4-(N-((R)-1-((3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)diisopropylsilyloxy)-pent-4-en-2-yl)-2-nitrophenylsulfonamido)cyclopent-2-enyl acetate

Conditions
ConditionsYield
With triphenylphosphine; diethylazodicarboxylate In tetrahydrofuran at 0 - 20℃; Fukuyama Coupling; Inert atmosphere;97%
(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

(1S,4R)-cis-1-ethoxycarbonyloxy-4-acetoxy-2-cyclopentene
128741-00-4

(1S,4R)-cis-1-ethoxycarbonyloxy-4-acetoxy-2-cyclopentene

Conditions
ConditionsYield
With pyridine at 0℃; for 1h;96.6%
With pyridine In dichloromethane for 2h; Ambient temperature;92%
(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

(R)-4-acetoxycyclopent-2-en-1-one
59995-48-1

(R)-4-acetoxycyclopent-2-en-1-one

Conditions
ConditionsYield
With dipyridinium dichromate96%
With oxalyl dichloride; dimethyl sulfoxide; triethylamine In dichloromethane94%
With oxalyl dichloride; dimethyl sulfoxide; triethylamine In dichloromethane at -78℃; Swern oxidation;94%
(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

acetic anhydride
108-24-7

acetic anhydride

ethyl 2-<(1R,4S)-4-(acetyloxy)-2-cyclopentenyl>-4-tert-butoxy-3-oxobutanoate

ethyl 2-<(1R,4S)-4-(acetyloxy)-2-cyclopentenyl>-4-tert-butoxy-3-oxobutanoate

Conditions
ConditionsYield
With dmap In dichloromethane at 0℃; for 4h;95%
(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

chloromethyl methyl ether
107-30-2

chloromethyl methyl ether

Acetic acid (1R,4S)-4-methoxymethoxy-cyclopent-2-enyl ester
198021-31-7

Acetic acid (1R,4S)-4-methoxymethoxy-cyclopent-2-enyl ester

Conditions
ConditionsYield
With dmap; N-ethyl-N,N-diisopropylamine95%
78%
(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

2,2,2-Trichloro-acetimidic acid (2R,3R,4S,5S,6R)-6-methyl-3,4,5-tris-triethylsilanyloxy-tetrahydro-pyran-2-yl ester
237763-47-2

2,2,2-Trichloro-acetimidic acid (2R,3R,4S,5S,6R)-6-methyl-3,4,5-tris-triethylsilanyloxy-tetrahydro-pyran-2-yl ester

Acetic acid (1R,4S)-4-((2S,3R,4S,5S,6R)-6-methyl-3,4,5-tris-triethylsilanyloxy-tetrahydro-pyran-2-yloxy)-cyclopent-2-enyl ester

Acetic acid (1R,4S)-4-((2S,3R,4S,5S,6R)-6-methyl-3,4,5-tris-triethylsilanyloxy-tetrahydro-pyran-2-yloxy)-cyclopent-2-enyl ester

Conditions
ConditionsYield
With trimethylsilyl trifluoromethanesulfonate In diethyl ether at -30℃; Etherification;95%
(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

methanesulfonyl chloride
124-63-0

methanesulfonyl chloride

(1S,4R)-Cis-1-methanesulfonyloxy-4-acetoxy-2-cyclopentene

(1S,4R)-Cis-1-methanesulfonyloxy-4-acetoxy-2-cyclopentene

Conditions
ConditionsYield
With triethylamine In dichloromethane95%
With triethylamine In dichloromethane95%
(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

1(R)-acetoxy-2,3(R,R),4(S)-trihydroxycyclopentane
114739-33-2

1(R)-acetoxy-2,3(R,R),4(S)-trihydroxycyclopentane

Conditions
ConditionsYield
With osmium(VIII) oxide; 4-methylmorpholine N-oxide In water; acetone94%
-butyl vinyl ether
111-34-2

-butyl vinyl ether

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

Acetic acid (1R,4S)-4-(1-butoxy-2-iodo-ethoxy)-cyclopent-2-enyl ester
879098-65-4

Acetic acid (1R,4S)-4-(1-butoxy-2-iodo-ethoxy)-cyclopent-2-enyl ester

Conditions
ConditionsYield
With N-iodo-succinimide In dichloromethane at 20℃; for 20h;93%
Benzyloxymethyl chloride
3587-60-8

Benzyloxymethyl chloride

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

(1S)-cis-4-Benzyloxymethylcyclopent-2-en-1-ol
934986-75-1

(1S)-cis-4-Benzyloxymethylcyclopent-2-en-1-ol

Conditions
ConditionsYield
Stage #1: Benzyloxymethyl chloride With bromine; magnesium; mercury dichloride In tetrahydrofuran at -5℃; for 2.5h;
Stage #2: (1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate In tetrahydrofuran at -20℃; for 0.25h; Further stages.;
92%
(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

sodium salt of di-tert-butyl iminodicarboxylate

sodium salt of di-tert-butyl iminodicarboxylate

di-tert-butyl [(1R,4S)-4-hydroxycyclopent-2-en-1-yl]imidodicarbonate
220241-57-6

di-tert-butyl [(1R,4S)-4-hydroxycyclopent-2-en-1-yl]imidodicarbonate

Conditions
ConditionsYield
tetrakis(triphenylphosphine) palladium(0) In tetrahydrofuran92%
(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

ethyl vinyl ether
109-92-2

ethyl vinyl ether

Acetic acid (1R,4S)-4-(1-ethoxy-2-iodo-ethoxy)-cyclopent-2-enyl ester

Acetic acid (1R,4S)-4-(1-ethoxy-2-iodo-ethoxy)-cyclopent-2-enyl ester

Conditions
ConditionsYield
With N-iodo-succinimide In dichloromethane at -20℃; for 4h;90%
With N-iodo-succinimide
(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

malonic acid dimethyl ester
108-59-8

malonic acid dimethyl ester

2-<(1R,4S)-4-hydroxycyclopent-2-enyl>malonsaeure-dimethylester
120052-50-8

2-<(1R,4S)-4-hydroxycyclopent-2-enyl>malonsaeure-dimethylester

Conditions
ConditionsYield
With potassium tert-butylate; tetrakis(triphenylphosphine) palladium(0) In tetrahydrofuran at 20℃; for 2h;90%
With potassium tert-butylate; tetrakis(triphenylphosphine) palladium(0) In tetrahydrofuran at 20℃; for 2h; Product distribution; Further Variations:; Reagents; Temperatures; reaction times;90%
With potassium carbonate; triphenylphosphine; tetrakis(triphenylphosphine) palladium(0) In tetrahydrofuran at 40℃; for 12h;73%
With tetrakis(triphenylphosphine) palladium(0); sodium hydride; triphenylphosphine 1.) THF, 2.) 1 h; Yield given. Multistep reaction;
With potassium tert-butylate; palladium
(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

4-nitro-benzoic acid
62-23-7

4-nitro-benzoic acid

p-Nitrobenzoic acid (1R,4R)-4-acetoxycyclopent-2-en-1-yl ester
289716-57-0

p-Nitrobenzoic acid (1R,4R)-4-acetoxycyclopent-2-en-1-yl ester

Conditions
ConditionsYield
With triphenylphosphine; diethylazodicarboxylate In tetrahydrofuran at 20℃; Esterification; Mitsunobu reaction;90%
(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate
60410-16-4

(1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate

chloroacetic acid
79-11-8

chloroacetic acid

(1R,4R)-4-acetoxycyclopent-2-en-1-yl chloroacetate
859509-52-7

(1R,4R)-4-acetoxycyclopent-2-en-1-yl chloroacetate

Conditions
ConditionsYield
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 20℃; for 2h;90%

60410-16-4Relevant articles and documents

A convergent, enantioselective total synthesis of streptogramin antibiotic (-)-madumycin II

Ghosh, Arun K.,Liu, Wenming

, p. 7908 - 7909 (1997)

-

Studies towards the total synthesis of an epoxy isoprostane phospholipid, a potent activator of endothelial cells.

Jung, Michael E,Kers, Annika,Subbanagounder, Ganesamoorthy,Berliner, Judith A

, p. 196 - 197 (2003)

We report studies toward the total synthesis of an epoxy isoprostane, namely the preparation of compound 9 which is an analogue of the elimination product 7 of the naturally occurring epoxy isoprostane 4 by a straightforward route using a three-component coupling, and have shown by several spectroscopic criteria that it closely resembles the natural material.

PALLADIUM-CATALYZED INTRAMOLECULAR OLEFIN ALLYLATIONS: STEREOCONTROLLED SYNTHESES OF BICYCLIC SYSTEMS AND EVIDENCE FOR AN ALLYLPALLADIUM/OLEFIN-CIS-INSERTION

Oppolzer, Wolfgang,Gaudin, Jean-Marc,Birkinshaw, Timothy N.

, p. 4705 - 4708 (1988)

Pd(0)-catalyzed cyclizations of (1-acetoxy-3-alkenyl)-2-cycloalkenes 3, 6 and 12 provide bicyclic systems in high diastereo- (5, 8) and enantio-meric (14) purity consistent with a predominant allylpalladium/alkene cis- insertion.

Acylative desymmetrization of cyclic meso-1,3-diols by chiral DMAP derivatives

Mandai, Hiroki,Hironaka, Tsubasa,Mitsudo, Koichi,Suga, Seiji

supporting information, p. 471 - 474 (2021/03/15)

An efficient enantioselective acylative desymmetrization of cyclic meso-1,3-diols was developed by using a chiral DMAP derivative 1e having a 1,1¤-binaphthyl unit. The reactions required only 0.5mol% of the catalyst and showed good to excellent enantioselectivity. With this transformation, 5a, a key building block for the synthesis of natural products, was easily obtained in almost enantiomerically pure form after a single recrystallization. Control experiments revealed that tert-alcohol units on the catalyst were responsible for both the catalytic activity and enantioselectivity.

Enantioselective Total Synthesis of (+)-Nordasycarpidone, (+)-Dasycarpidone, and (+)-Uleine

Delayre, Bastien,Fung, Cédric,Wang, Qian,Zhu, Jieping

, (2021/07/12)

The structure of uleine type alkaloids is characterized by the presence of a bridged tetracyclic hexahydro-1H-1,5-methanoazocino[4,3-b]indole ring system 1. Various strategies have been developed to access this polycyclic structural motif. We report herein a one-step conversion of appropriately functionalized 1,3,4-trisubstituted cyclopent-1-ene to 1 by way of an integrated oxidation/reduction/cyclization (iORC) process. This domino sequence, initiated by oxidative cleavage of cyclopentene ring, generated subsequently a cyclohexenone, an indole and a 1,3-bridged piperidine ring through formation of one C?C and two C?N bonds. Compound 1 is subsequently converted to nordasycarpidone, dasycarpidone and uleine. The chirality of the molecule was introduced by enzymatic desymmetrization of commercially available meso cis-3,5-diacetoxy-1-cyclopentene.

TiCl3-Mediated Synthesis of 2,3,3-Trisubstituted Indolenines: Total Synthesis of (+)-1,2-Dehydroaspidospermidine, (+)-Condyfoline, and (?)-Tubifoline

Delayre, Bastien,Piemontesi, Cyril,Wang, Qian,Zhu, Jieping

supporting information, p. 13990 - 13997 (2020/06/10)

2,3,3-Trisubstituted indolenine constitutes an integral part of many biologically important monoterpene indole alkaloids. We report herein an unprecedented access to this skeleton by a TiCl3-mediated reductive cyclization of tetrasubstituted alkenes bearing a 2-nitrophenyl substituent. The proof of concept is demonstrated firstly by accomplishing a concise total synthesis of (+)-1,2-dehydroaspidospermidine featuring a late-stage application of this key transformation. A sequence of reduction of nitroarene to nitrosoarene followed by 6π-electron-5-atom electrocyclization and a 1,2-alkyl shift of the resulting nitrone intermediate was proposed to account for the reaction outcome. A subsequent total synthesis of (+)-condyfoline not only illustrates the generality of the reaction, but also provides a mechanistic insight into the nature of the 1,2-alkyl shift. The exclusive formation of (+)-condyfoline indicates that the 1,2-alkyl migration follows a concerted Wagner–Meerwein pathway, rather than a stepwise retro-Mannich/Mannich reaction sequence. Conditions for almost quantitative conversion of (+)-condyfoline to (?)-tubifoline by way of a retro-Mannich/1,3-prototropy/transannular cyclization cascade are also documented.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 60410-16-4